精优药业因可换股债转股发行3.5亿股股份 占比13.73%

公告速递
Apr 14

精优药业控股有限公司(00858)于2026年4月14日发布公告,披露公司根据早前发行的可换股债券转换安排,以每股0.6413港元的发行价增发3.5亿股新股份,合计金额约2.24亿港元。该批股份约占本次发行前公司已发行股本的13.73%。

本次增发完成后,公司已发行股本由25.5亿股增加至29亿股。公司在公告中确认,相关发行事宜已获得董事会正式授权,并严格遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由执行董事及公司秘书王秀娟签署。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10